These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6377715)

  • 1. [Value of preventive immunoglobulin administration in cadaveric kidney transplantation].
    Steiner E; Aigner F; Kathrein H; Huber C; Margreiter R
    Wien Klin Wochenschr; 1984 Mar; 96(7):264-6. PubMed ID: 6377715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H; Otte B; Lang D; Heidenreich S
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-dose daclizumab induction protocol in renal allograft recipients: a Chinese single center experience.
    Ji SM; Li LS; Cheng Z; Cheng DR; Sun QQ; Chen JS; Sha GZ; Liu ZH
    Transplant Proc; 2007 Jun; 39(5):1396-401. PubMed ID: 17580147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wound infections in renal transplant recipients--a complication of urinary tract infections during allograft malfunction.
    Lobo PI; Rudolf LE; Krieger JN
    Surgery; 1982 Sep; 92(3):491-6. PubMed ID: 7051386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?
    Cheung CY; Liu YL; Wong KM; Chan HW; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Shek CC; Li CS
    Nephrology (Carlton); 2008 Jun; 13(3):251-5. PubMed ID: 18221256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
    Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
    Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study.
    Stratta RJ; Alloway RR; Lo A; Hodge E
    Transplantation; 2003 Apr; 75(8):1260-6. PubMed ID: 12717213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized prospective trial of oral versus intravenous ganciclovir for prophylaxis of cytomegalovirus infection and disease in high-risk kidney recipients.
    Nafar M; Pezeshki ML; Farrokhi F; Einollahi B; Pour-Reza-Gholi F; Firouzan A; Farhangi S
    Transplant Proc; 2005 Sep; 37(7):3053-5. PubMed ID: 16213302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.
    Goggins WC; Pascual MA; Powelson JA; Magee C; Tolkoff-Rubin N; Farrell ML; Ko DS; Williams WW; Chandraker A; Delmonico FL; Auchincloss H; Cosimi AB
    Transplantation; 2003 Sep; 76(5):798-802. PubMed ID: 14501856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
    Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
    Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early urinary tract infection in kidney transplantation. Risk factors and impact on graft survival].
    Cepeda PA; Balderramo DC; De Arteaga J; Douthat WG; Massari PU
    Medicina (B Aires); 2005; 65(5):409-14. PubMed ID: 16296636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious complications after simultaneous pancreas-kidney transplantation.
    Michalak G; Kwiatkowski A; Bieniasz M; Meszaros J; Czerwinski J; Wszola M; Nosek R; Ostrowski K; Chmura A; Danielewicz R; Lisik W; Adadynski L; Fesołowicz S; Dobrowolska A; Durlik M; Rowiñski W
    Transplant Proc; 2005 Oct; 37(8):3560-3. PubMed ID: 16298661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyomavirus nephropathy after renal transplantation: a single centre experience.
    Kim HC; Hwang EA; Han SY; Park SB; Park KK
    Nephrology (Carlton); 2005 Apr; 10(2):198-203. PubMed ID: 15877682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
    Weinrauch LA; D'Elia JA; Gleason RE; Shaffer D; Monaco AP
    Clin Nephrol; 1995 Sep; 44(3):185-92. PubMed ID: 8556835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.